These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 1006811)

  • 1. In vivo inhibition of antitumor immunity by embryonic antigens.
    Lembo R; Parmiani G
    Tumori; 1976; 62(2):211-8. PubMed ID: 1006811
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparative effect of Mycobacterium bovis- and neuraminidase-treated tumor cells on the growth of established methylcholanthrene fibrosarcomas in syngeneic mice.
    Rios A; Simmons RL
    Cancer Res; 1972 Jan; 32(1):16-21. PubMed ID: 4550256
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of different cancer treatment methods on immunity to an antigenic transplantable murine fibrosarcoma (Meth A).
    Khafagy M; Wanebo HJ; Alfieri A; Hahn EW
    AJR Am J Roentgenol; 1977 Jun; 128(6):1027-9. PubMed ID: 414534
    [No Abstract]   [Full Text] [Related]  

  • 4. Tumor-specific immunity in 3-methylcholanthrene-induced murine fibrosarcomas. I. In vivo demonstration of immunity with three preparations of soluble antigens.
    Brannen GE; Adams JS; Santos GW
    J Natl Cancer Inst; 1974 Jul; 53(1):165-75. PubMed ID: 4600504
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of anti-embryo immunization on methylcholanthrene-induced sarcoma growth in BALB/c mice.
    Parmiani G; Lembo R
    Int J Cancer; 1974 Oct; 14(4):555-64. PubMed ID: 4617712
    [No Abstract]   [Full Text] [Related]  

  • 6. Tumor-associated transplantation antigen distinct from H-2k-like antigens on a BALB/c (H-2d) fibrosarcoma.
    Parmiani G; Meschini A; Invernizzi G; Carbone G
    J Natl Cancer Inst; 1978 Nov; 61(5):1229-34. PubMed ID: 81882
    [No Abstract]   [Full Text] [Related]  

  • 7. Immunospecific regression of methylcholanthrene fibrosarcoma using neuraminidase. 3. Synergistic effect of BCG and neuraminidase treated tumor cells.
    Simmons RL; Rios A
    Ann Surg; 1972 Aug; 176(2):188-94. PubMed ID: 4562008
    [No Abstract]   [Full Text] [Related]  

  • 8. Cellular immune responses to methylcholanthrene-induced fibrosarcoma in BALB/c mice.
    Bhatnagar RM; Zabriskie JB; Rausen AR
    J Exp Med; 1975 Oct; 142(4):839-55. PubMed ID: 1185107
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro activity of lymphocytes and serum of C3Hf-Bu mice during the growth of methylcholanthrene-induced tumor and its regression following local irradiation.
    Jurin M; Suit HD
    Cancer Res; 1974 Apr; 34(4):672-8. PubMed ID: 4814987
    [No Abstract]   [Full Text] [Related]  

  • 10. Specific desensitization of resistance against a syngeneic methylcholanthrene-induced sarcoma in C3Hf mice.
    Vaage J
    Cancer Res; 1972 Feb; 32(2):193-9. PubMed ID: 5058179
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of regional lymphadenectomy on development of concomitant immunity.
    Soloway MS; Pendergrast WJ; Myers GH
    Surg Forum; 1972; 23(0):101-2. PubMed ID: 4671039
    [No Abstract]   [Full Text] [Related]  

  • 12. Demonstration of tumor-associated immunity with a leukocyte adherence inhibition (LAI) assay.
    Hellström I; Hellström KE; Shantz G
    Int J Cancer; 1976 Sep; 18(3):354-61. PubMed ID: 955746
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of cellular immunity to tumor-associated antigen(s) in mice by the macrophage spreading inhibition test.
    Svoboda I; Măzuran R; Rabatić S; Silobrcić
    Int J Cancer; 1977 Mar; 19(3):371-7. PubMed ID: 844913
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Passive transfer of tumor-specific resistance to methylcholanthrene-induced sarcomas in rats.
    Ishikawa Y; Fukushima M; Sato T; Komaba M; Yagihashi H
    Tohoku J Exp Med; 1971 Feb; 103(2):195-201. PubMed ID: 5580594
    [No Abstract]   [Full Text] [Related]  

  • 15. In vivo and in vitro studies of the influence of the immune status of C3Hf-Bu mice on the effectiveness of local irradiation of a methylcholanthrene-induced fibrosarcoma.
    Jurin M; Suit HD
    Cancer Res; 1972 Oct; 32(10):2201-11. PubMed ID: 5080765
    [No Abstract]   [Full Text] [Related]  

  • 16. Cell-mediated suppression of tumor immunity has a non-specific component. I. Evidence from transplantation tests.
    Hellström KE; Hellström I
    Int J Cancer; 1981; 27(4):481-5. PubMed ID: 6168591
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro demonstration of cryosurgical augmentation of tumor immunity.
    Faraci RP; Bagley DH; Marrone J; Beazley RM
    Surgery; 1975 Mar; 77(3):433-8. PubMed ID: 1124499
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunological resistance to pulmonary metastases in C3Hf-Bu mice bearing syngeneic fibrosarcoma of different sizes.
    Milas L; Hunter N; Mason K; Withers HR
    Cancer Res; 1974 Jan; 34(1):61-71. PubMed ID: 4809463
    [No Abstract]   [Full Text] [Related]  

  • 19. Cells from chemically induced mouse sarcomas retain tumor-specific transplantation antigenicity during prolonged passage in vitro.
    Walker R; Hellström I; Hellström KE
    Int J Cancer; 1980 Mar; 25(3):345-8. PubMed ID: 7390657
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibody response of mice to chemically induced tumors.
    Brown JP; Klitzman JM; Hellström I; Nowinski RC; Hellström KE
    Proc Natl Acad Sci U S A; 1978 Feb; 75(2):955-8. PubMed ID: 204940
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.